Vernalis loses CEO and US business in shake-up
Peter Fellner, the executive chairman of Vernalis, has orchestrated a huge restructuring at the loss-making biotechnology company that will see it retreat from America, cut more than half of its workforce, and result in the departure of its chief executive.
Mr Fellner, the former head of Celltech and one of the most respected figures in the UK biotech industry, said yesterday that he plans to return the company once known as British Biotech to its roots as a research and development-focused company with operations centred in Cambridge. The aggressive programme unveiled yesterday will undo most of what was done by chief executive Simon Sturge, who tried to reshape the company through a series of acquisitions into a speciality pharmaceutical company focused on America.
Mr Sturge will leave next month. Vernalis's cash-burn will be reduced from about £20m per year to £9m through the cutting of its 210-strong workforce to 90, with at least half the redundancies coming to the US salesforce.
Vernalis also reached a crucial settlement on a $56m (£28m) loan that it had taken out from partner Endo Pharmaceuticals. Under the deal, the company agreed to repay $7m to Endo and give up its rights to US royalties from migraine medication Frova. Under the original financing terms, Vernalis would have had to pay back the loan in its entirety by August next year, a worry that has weighed heavily on the cash-poor company.
Mr Fellner said he was in talks with three bidders interested in buying its Parkinson's treatment Ap-okyn. Doing so would complete the company's exit from America.
- 1 Planes go hybrid-electric in important step to greener flight
- 2 Antonio Martin shooting: Police and protesters clash over teenager's death just five miles from Ferguson, Missouri
- 3 British actor Idris Elba cannot star as James Bond because he is black, says shock jock Rush Limbaugh
- 4 Hip hop is both racial and political, and for Iggy Azalea to suggest otherwise is insulting
- 5 Man hospitalised with pneumonia after downing eggnog at office Christmas party
British actor Idris Elba cannot star as James Bond because he is black, says shock jock Rush Limbaugh
Rozanne Duncan: Ukip expels councillor for 'jaw-dropping' comments made in BBC TV interview
Germany anti-Islam protests: 17,000 march on Dresden against 'Islamification of the West'
Ukip member gets into Christmas spirit with Union Flag plea to Santa 'for our country back'
BBC director Danny Cohen: Rising UK antisemitism makes me feel more uncomfortable than ever
Alex Salmond has 'broken his word to the Scottish people' says Scottish Lib Dem leader
iJobs Money & Business
Highly Competitive: Selby Jennings: Our client, a leading European Oil trading...
£43500 per annum + pension + holidays: The Jenrick Group: Night Shift Operatio...
£20000 - £25000 per annum + OTE £40,000 + Car + Pension: SThree: SThree are a ...
£20000 - £25000 per annum + OTE £35K: SThree: We consistently strive to be the...